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Abstract: Soy sauce, a dark-colored seasoning, is added to enhance the sensory properties of foods. Soy sauce can
be consumed as a condiment or added during the preparation of food. There are 3 types of soy sauce: fermented,
acid-hydrolyzed vegetable protein (acid- HVP), and mixtures of these. 3-Chloropropane-1,2-diol (3-MCPD) is a heat-
produced contaminants formed during the preparation of soy sauce and was found to be a by-product of acid-HVP-
produced soy sauce in 1978. 3-MCPD has been reported to be carcinogenic, nephrotoxic, and reproductively toxic in
laboratory animal testing and has been registered as a chemosterilant for rodent control. 3-MCPD is classified as a possible
carcinogenic compound, and the maximum tolerated limit in food has been established at both national and international
levels. The purpose of this review is to provide an overview on the detection of 3-MCPD in soy sauce, its toxic effects,
and the potential methods to reduce its concentration, especially during the production of acid-HVP soy sauce. The
methods of quantification are also critically reviewed with a focus on efficiency, suitability, and challenges encountered
in analysis.
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Introduction: 3-MCPD and Its Importance
3-MCPD is one of the chloropropanol compounds which
consist of majorly 5 substances (Figure 1): 2-monochloropropane-
1,3-diol (2-MCPD), 2,3-dichloropropan1-ol (2,3-DCP), 1,3-
dichloropropan-2-ol (1,3-DCP), 3-monochloropropan-1-ol, and
3-chloropropane-1,2-diol (3-MCPD). 3-MCPD is a 3-carbon
compound with 2 functional alcohol groups and a chloride and
has the molecular formula C3H7CIO2 and a relative molecular
mass of 110.54 g/mol. 3-MCPD is a colorless liquid but has a
tendency to turn straw-yellow and is soluble in water, alcohol,
diethyl ether, and acetone (IARC 2013). Industrially, 3-MCPD
has been used to lower the freezing point of dynamite, as a dye
intermediate, as a rodent chemosterilant, and as a solvent for cellu-
lose acetate (NJDHSS 1999). 3-MCPD was listed as a rodenticide
under the name “alpha-chlorohydrin” by the U.S. Environmental
Protection Agency (EPA 2013). In the food industry, 3-MCPD
is a by-product of acid-hydrolyzed vegetable protein (acid-HVP)
production. The acid hydrolysis of vegetable protein is a process
used to mass-produce artificial soy sauce in a short period of time,
without the fermentation process. Medium-high and high con-
centrations of 3-MCPD consumed in a short period have been
found to cause kidney and reproductive organ failure. In some
cases, especially in rats fed with high doses of 3-MCPD for a
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prolonged period, 3-MCPD has been reported to cause hyper-
plasia and tumors in kidneys and reproductive organs. With the
available toxicology reports, International Agency for Research
on Cancer (IARC) has classified 3-MCPD as a Group 2B car-
cinogen, which means that it is possibly carcinogenic to hu-
mans, and the OEHHA has also characterized it as Proposition
65 (Prop. 65), which refers to a substance that can cause can-
cer, birth defects, and other reproductive harm (OEHHA 2010a;
IARC 2014).
Besides 3-MCPD, 1,3-DCP is another genotoxic carcinogen
from the chloropropanol group. Unlike 3-MCPD, 1,3-DCP has
only 1 alcohol functional group, but it has 2 chloride ions. 1,3-
DCP is widely used in several industries as a key chemical in the
synthesis of polymers, fumigants, synthetic glycerol, and dye fixa-
tives in detergents (NTP 2005; OEHHA 2010b). Besides playing
an important role in industrial organic synthesis, 1,3-DCP is also
found in low concentrations in acid-HVP, albeit lower than the
concentration of 3-MCPD (European Commission 2004). The
ratio range of 1,3-DCP to 3-MCPD is between 1:2 and 1:3630
(European Commission 2004). 1,3-DCP is formed from 3-MCPD
in the presence of acetic acid (HOAc) (Collier and others 1991).
Intermediate and high dosages of 1,3-DCP were reported to be
having carcinogenic effects in the liver, kidney, oral epithelium
and tongue, and thyroid glands of laboratory rats (JECFA 2002).
Available toxicity results have shown that 1,3-DCP is a genotoxic,
hepatotoxic, and cancer-inducing agent, and it has been classified
as being possibly carcinogenic to humans (group 2B) and placed
on the Prop. 65 list (OEHHA 2010b; IARC 2014).
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Figure 1–Chloropropanols.
The detection of 3-MCPD in soy sauce is vital, as it is one of the
most widely used seasonings in Asian food preparation. Soy sauce
consumption worldwide is estimated at 10 billion liters (L). Soy
sauce consumption per capita in the USA is 0.8 L, while in Japan
it is 9 L a year (Tokyo 2004). In China, soy sauce consumption
is estimated to be 9 mL per person per day (Huo and others
2013). These data show that the consumption of soy sauce is quite
high, especially in Asian regions. The main exporter of soy sauce
in 2011 was China (94143 tons), followed by The Netherlands
(34673 tons). The main importer for soy sauce in 2011 was the
USA (59298 tons), followed by Hong Kong (22519 tons) and
the United Kingdom (19576 tons) (FAOSTAT 2011), illustrating
that soy sauce is consumed worldwide. Soy sauce has also been
used as a flavor enhancer in ready-to-eat foods such as sausages
and instant noodles. These foods are likely contaminated with
3-MCPD if 3-MCPD contaminated acid-HVP soy sauce is a raw
ingredient. In addition to 3-MCPD, there are other contaminants
found in soy sauce that are detrimental to health, for example,
ethyl carbamate can be found in fermented soy sauce (Matsudo
and others 1993). However, the main concern is that 3-MCPD
found in acid-HVP soy sauce can cause kidney and reproductive
organ failure. Acid-HVP can be produced rapidly compared with
traditional fermented soy sauce. Research on 3-MCPD in acid-
HVP soy sauce is important to ensure that the soy sauce added to
foods is safe. The method of detection plays an important role in
reducing the risk of 3-MCPD contamination in soy sauce. Fast,
accurate, and reliable quantification of 3-MCPD will assist in the
creation of Hazard Analysis and Critical Control Points (HACCP)
in the production of soy sauce.
3-MCPD is formed in heat-processed foods in the presence of
lipids and chloride ions (Figure 2). Formation of 3-MCPD is found
to be highest when chloride reacts with lecithin, followed by the
reaction of diacylglycerols and glycerol (Velisek and others 2003).
Acid hydrolysis is the process known to produce acid-hydrolyzed
soy sauce without bacterial fermentation. Traditional brewing of
soy sauce involves 2 steps, namely, koji and brine/moromi fer-
mentation. 3-MCPD will not be formed in fermented soy sauce,
as there is no high temperature treatment involved.
Formation of 3-MCPD in Acid-HVP Soy Sauce
Acid-HVP soy sauce is made without microbial fermentation,
while traditionally made soy sauce requires fermentation to break
down the soy protein into aromatic compounds that give rise
to the aroma and taste of the sauce. It requires a fermentation
period of approximately 4 mo, depending on the type of soy
sauce being produced and the bacteria used. Fermentation does
not involve high-temperature treatment, as that would kill the
microbes. In contrast, acid-HVP soy sauce can be produced in
just a few days. Production begins with mixing defatted soy beans,
wheat gluten, and/or corn meal (Figure 3). Then, the mixture
undergoes hydrolysis with 4 to 9 molar (M) aqueous hydrochloric
acid (HCl). The hydrolysis requires prolonged heating (20 to 35 h)
at high temperatures (103 to 110 °C). The prolonged heating in
high temperature is believed to be responsible for the formation of
3-MCPD in the production of acid-HVP soy sauce, likely due to
the presence of glycerol, lecithin, and other glycerides in the soy
sauce itself. The mixture subsequently undergoes neutralization
with sodium carbonate (Na2CO3) or sodium hydroxide (NaOH)
to remove any excess HCl. It is then refined by sedimentation, and
filtered to remove undesirable aromatic compounds (FAO 2012).
Reduction of 3-MCPD during HVP Soy Sauce
Production
Modifications can bemade to reduce the formation of 3-MCPD
in acid-HVP soy sauce. The FAO (2012) have proposed 3 meth-
ods for 3-MCPD reduction: careful control of acid hydrolysis,
alkaline treatment after acid hydrolysis, and the substitution of
HCl with sulfuric acid (H2SO4) (Figure 3). To further reduce the
concentration of 3-MCPD in the final acid-HVP product, an en-
zymatic removal process can be introduced to the production line.
3-MCPD formation can also be completely prevented by using
alkaline hydrolysis instead of acid hydrolysis of vegetable protein
(Hall 1946). The reduction of 3-MCPD will also directly reduce
the concentration of 1,3-DCP in the soy sauce, since 1,3-DCP
is formed in the presence of 3-MCPD and HOAc (Collier and
others 1991; Huang and others 2013).
Careful control of the acid hydrolysis step is crucial for the re-
duction of 3-MCPD, as this is when the production of 3-MCPD
occurs. In conventional acid-HVP production, high temperatures
and concentrated HCl are present for long periods of time. The
concentration of HCl can be reduced to minimize the introduc-
tion of chloride ions through the addition of HCl. However, the
reduction in HCl concentration will also reduce the efficiency of
acid hydrolysis. To optimize the low HCl concentration acid hy-
drolysis process, the temperature of the reaction must be increased
gradually with a particular holding time. The gradual increase in
temperature increases the efficiency of HCl at low concentrations
(FAO 2012).
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Figure 2–Formation of 3-MCPD and 2-MCPD from glycerol (Collier and others 1991).
An alkaline treatment can also be applied after acid hydrolysis
to reduce the concentration of 3-MCPD (Figure 3). 3-MCPD
was found to be unstable at alkaline pH (Hamlet and others 2003;
Reece 2005; FAO and WHO 2007), and a pH higher than 6
would be sufficient to cause the degradation of 3-MCPD. A com-
bination of alkaline and heat treatment after acid hydrolysis would
efficiently reduce the concentration of 3-MCPD formed during
acid hydrolysis.
The chloride ion is important for the formation of 3-MCPD
from fatty acids. Removal of chloride ions in acid hydrolysis would
eliminate the formation of 3-MCPD. In the acid hydrolysis pro-
cess, acid is added to the system as a catalyst. H2SO4 can be used
instead of HCl to perform the acid hydrolysis, but is not prefer-
able as H2SO4 will not result in a high yield of amino acids in
the end product. This is because the second proton in H2SO4 is
not utilized in the hydrolysis and it likely affects the stability of
amino acids after they had been hydrolyzed (Flork 1989). Thus, in
order to produce H2SO4-hydrolyzed vegetable proteins with the
required taste profile, flavorings such as monosodium glutamate,
caramel, disodium inosinate, disodium guanylate, and lactic acid
will have to be added to the final product (FAO 2012).
3-MCPD can also be removed through an enzymatic reaction.
Bornscheuer and Hesseler (2010) reported on the enzymatic re-
moval of 3-MCPD and its ester from oils. 3-MCPD can be re-
moved by the enzyme halohydrin dehalogenase (HHD) extracted
from Arthrobacter sp. AD2. The end product, glycidol, would then
be hydrolyzed to glycerol by epoxide hydrolase (Figure 4). How-
ever, this reaction requires a long time for degradation and the
3-MCPD is not completely degraded, even after 24 h. The pilot-
scale study was conducted with a basic buffer at 30 °C. Therefore,
with the current technology, the enzymatic removal method is
not suitable for large-scale implementation in the industry be-
cause it requires optimization and immobilization of enzymes.
In addition to the enzyme from Arthrobacter sp. AD2 reported by
Bornscheuer and Hesseler (2010), there are also a number of other
HHDs that can be applied to degrade 3-MCPD. The efficiencies
of HHDs from different bacterial species were well reviewed by
You and others (2013). HHD has also been found to effectively
degrade halogenated organic compounds (HOCs), which include
1,3-DCP. In fact, some HHDs were found to be more effective in
the removal of 1,3-DCP than in removing 3-MCPD.
Alkaline hydrolysis would be an alternative to acid hydrolysis,
but it is carried out less often in industry-scale production because
it requires continued cooking of the amino acids, rendering the
product to be partially racemized and thus undesirable (Borken-
hagen 1953). Generally, the process of generating alkaline-HVP
starts with heating to dissolve the proteins, and then an alkaline
agent such as calcium, sodium, or potassium hydroxide is added.
The temperature is then increased to a certain point between
27 °C and 54 °C, and hydrolysis is carried out for several hours
until the desired end products meet the required amino acid pro-
files (Pasupuleti and Braun 2010). Alkaline-HVP contains an un-
acceptable flavor profile and unbalanced amino acid content as
compared with acid-HVP (Reineccius 2006). The advantage of
using alkaline hydrolysis is that there will be less or little humin
formed after the hydrolysis process (Hall 1946).
Maximum Tolerable Limits and the Occurrence of
3-MCPD in Soy Sauce and Related Products
The European Union (Commission Regulation 2001) has set
a maximum limit for 3-MCPD of 0.02 mg/kg for soy sauce
and 0.05 mg/kg (dry weight) for other foods containing acid-
HVP (Table 1) and recommended a tolerable daily intake (TDI)
of 0.002 mg/kg bw (European Commission 2006). The TDI
was established on the basis of toxicity information available for
3-MCPD.Malaysia has also set a limit of 0.02 mg/kg in liquid food
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Figure 3–(Left) Conventional production of acid-HVP. (Right) Dotted box, proposed modification for reduction of 3-MCPD production (FAO 2012).
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Figure 4–Proposed metabolic pathway for 3-MCPD based on bacterial and putative mammalian pathways (Lynch and others 1998).
with acid HVP and 1.00 mg/kg for acid HVP (Laws of Malaysia
2012). The United States (FDA 2008) and Canada (Canadian
Standards 2012) have both set the limit for detectable 3-MCPD
in foods at 1.00 mg/kg. Australia and New Zealand have set a
maximum of 0.20 mg/kg for 3-MCPD in soy and oyster sauces
(Food Standards Australia New Zealand Act 1991). Previous stud-
ies have reported that 3-MCPD has been detected in soy sauce
and related products (Table 2). Surveys and case studies have been
conducted in the United Kingdom (Macarthur and others 2000),
Taiwan (Cheng and others 2004), New Zealand (MAF 2011),
Hong Kong (Chung and others 2008), the United States (Nyman
and others 2003), Singapore (Wong and others 2006), Spain (Leon
and others 2008), Brazil (Vicente and others 2011), and Belgium
(Christova-Bagdassarian and others 2013). TheWTOCommittee
on Sanitary and Phytosanitary Measures (WTO 2002) ensures that
3-MCPD-contaminated products in international trade are within
the required limits.
Cheng and others (2004) conducted a survey on the 3-MCPD
contents of soy sauce in products in Taiwan during the 2002 fiscal
year. A total of 214 samples were collected, in commercial areas of
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Table 1–International maximum tolerable amount of 3-MCPD in foods.
Country Maximum limit Scope Reference
Australia/New Zealand 0.20 mg/kg Soy and oyster Sauce (40% dry matter content) (Food Standards Australia New Zealand Act 1991)
Canada 1.00 mg/kg Soy and oyster Sauce (Canadian Standards 2012)
China 1.00 mg/kg Acid HVP seasoning (National Standard of the People’s Republic China 2000)
European Union (EU) 0.02 mg/kg HVP and soy sauce (Commission Regulation 2001)
Malaysia 0.02 mg/kg Liquid food with acid HVP (Laws of Malaysia 2012)
1.00 mg/kg Acid HVP
Singapore 0.02 mg/kg Soy and related sauces (Wong and others 2006)
United States 1.00 mg/kg Acid HVP (FDA 2008)
Taiwan, of which 118 were domestic and 26 were imported. The
limit of detection (LOD) method used was 0.01 mg/kg. There
were 87 domestic samples and 23 imported samples that contained
undetected concentrations of 3-MCPD, 91 domestically manufac-
tured soy sauces that contained 3-MCPD levels between 0.01 and
1.00 mg/kg, and 10 samples that contained 3-MCPD concentra-
tions of more than 1.00 mg/kg, which is over the limit required
by the Taiwanese government. Meanwhile, for imported sauces,
3 samples in which 3-MCPD was detected contained between
0.01 mg/kg and 0.03 mg/kg.
3-MCPD levels in 421 soy and oyster sauces in Singapore were
investigated in a case study by Wong and others (2006). The re-
porting limit and lowest calibration point for the method used
were 0.01 mg/kg and 0.05 × 10−1 mg/kg, respectively. The na-
tional maximum limit of 3-MCPD for Singapore is 0.02 mg/kg.
In total, 376 samples were found to contain 3-MCPD levels at or
below 0.02 mg/kg, and 3 out of the 58 domestically manufactured
and 42 out of the 363 imported sauces contained 3-MCPD lev-
els over the recommended limit. The highest quantified levels of
3-MCPD were in a soy sauce from Thailand and an oyster sauce
from Taiwan.
Nyman and others (2003) conducted a survey on chloro-
propanols in soy sauces and related products in the United States.
The LOD for the survey was 0.05 × 10−1 mg/kg. A total of
55 samples were purchased from retail markets in Baltimore and
Washington, and the results showed that there were 19 samples
that contained levels of 3-MCPD over the limit of 1.0 mg/kg.
All of the samples that did not meet the requirements were im-
ported from Asia: Hong Kong, Vietnam, China, the Philippines,
and Thailand. All of the domestically manufactured samples met
the requirement. The highest 3-MCPD quantified in the study
was 876 mg/kg in a sample from Hong Kong.
Crews and others (2003) conducted a survey of chloropropanols
in soy sauce and related products purchased in the United
Kingdom in 2000 and 2002. The detection method used was the
standard AOAC method. One hundred samples of soy sauce and
related products were purchased from retail outlets in the United
Kingdom in 2000, and in 2002, 99 samples were purchased from
5 areas in the United Kingdom. The results from 2000 were com-
pared with those of 2002. In 2000, 32% of the samples contained
levels of 3-MCPD over the limit (0.02 mg/kg) and 16 samples
contained more than 1 mg/kg. However, the majority of samples
had levels of 3-MCPD below 0.10 mg/kg. In 2002, only 8 of the
99 samples contained levels of 3-MCPD more than 0.01 mg/kg.
Soy sauce and related products containing more than 0.01 mg/kg
3-MCPD were greatly reduced from 2000 to 2002.
Vicente and others (2011) conducted a survey of chloro-
propanols (3-MCPD and 1,3-DCP) in soy sauce and similar prod-
ucts from Brazil. A total of 45 samples of soy sauce and 16 products
containing soy sauce were collected from the Brazilian market-
place. The LOD for the method used was 0.09 × 10−1 mg/kg.
Seven samples of soy sauce were found to be positive for 3-MCPD,
and all of the samples containing 3-MCPD ranged from unde-
tectable to 4.405 mg/kg. 3-MCPD was undetected in all of the
soy-containing special sauces.
A survey of 3-MCPD in soy sauce from Bulgaria was conducted
by Christova-Bagdassarian and others (2013). The LOD reported
in the survey was 0.23 × 10−2 mg/kg. A total of 21 soy sauce sam-
ples were collected from the Bulgarian marketplace. The majority
of samples where the levels of 3-MCPD did not comply with EU
regulations originated from Bulgaria, but the soy sauces imported
from China did comply with EU requirements.
There are also technical reports available on the occurrence of
3-MCPD in soy sauce reported by local food safety enforcement
groups. FSANZ (2003) surveyed the occurrence of 3-MCPD in
foods and included soy sauce and soy products. The method of
detection for the survey was the official AOAC method with an
LOD of 0.01 mg/kg. A total of 39 samples of soy sauce and soy
products were collected and 18 samples were reported to contain
levels of 3-MCPD above the LOD, and among these, 14 sam-
ples contained 3-MCPD concentrations higher than the limit of
0.02 mg/kg. The highest concentration of 3-MCPD detected was
148.2 mg/kg in a soy seasoning sauce. Out of the 8 soy seasoning
sauces, 7 contained levels of 3-MCPD above the limit of 0.02
mg/kg. In a newspaper article, the Malaysian government was said
to have recalled 22 sauces and seasoning products of 11 different
brands imported from 5 Asian countries that were found to have
concentrations of 3-MCPD higher than the 0.02 mg/kg limit
(Sennyah 2001).
In the “Report of Experts for Scientific Cooperation Task
3.2.9,” the European Union collected data on the levels of
3-MCPD and related substances in foodstuffs (European
Commission 2004). The report contains data of chloropropanol in
soy sauces and foods other than soy sauces. There were a total of
10 countries involved in the cooperative study. In Austria, out of
316 samples of soy sauces, there were 130 samples that contained
a quantifiable level of 3-MCPD, and the highest concentration of
3-MCPD detected was 104 mg/kg. In Denmark, out of 43 sam-
ples, there were a total of 27 samples with quantifiable concen-
trations of 3-MCPD, and the highest concentration of 3-MCPD
detected was 90.0 mg/kg. In Finland, 53 out of 163 samples col-
lected contained quantifiable concentrations of 3-MCPD, and the
highest concentration reported was 940 mg/kg. In France, 39
of 73 samples collected contained quantifiable concentrations of
3-MCPD. In Germany, it was reported that 198 out of 692
samples collected contained quantifiable levels of 3-MCPD.
In Ireland, 47 out of 178 samples were reported to contain quan-
tifiable concentrations of 3-MCPD, and the highest concentration
of 3-MCPD reported was 1779 mg/kg detected in light soy sauce
samples. The Netherlands reported that out of 273 samples, there
were a total of 77 samples that contained quantifiable concentra-
tions of 3-MCPD, and the highest concentration of 3-MCPD was
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151 mg/kg. Norway reported that 47 out of 51 samples collected
contained quantifiable concentrations of 3-MCPD, and the highest
3-MCPD quantified was 146 mg/kg. Sweden reported that out of
76 samples, 31 contained quantifiable concentrations of 3-MCPD.
The United Kingdom reported that 65 of 170 samples contained
quantifiable concentrations of 3-MCPD, and the highest concen-
tration of 3-MCPD reported was 93.1 mg/kg. In these reports,
there were samples contaminated with high concentrations of
3-MCPD, some up to 100 mg/kg. Though the EU enforced the
maximum tolerable limit of 0.02 mg/kg for 3-MCPD, there were
still soy sauces and related products with 3-MCPD concentrations
above the permitted limits.
Surveys conducted on 3-MCPD in soy sauces and related prod-
ucts in locally available markets have had a significant impact on the
enforcement of maximum tolerances of 3-MCPD in food sam-
ples. Crews and others (2003) compared survey data with those of
Macarthur and others (2000) for differences in 3-MCPD in soy
sauce between 1999, 2000, and 2002. For samples containing more
than 0.10mg/kg 3-MCPD, there was a decreasing trend, from 48%
in 1999 to 31% in 2000 to 8% in 2002. Samples containing more
than 1 mg/kg 3-MCPD decreased from 23% in 1999 to 17% in
2000 and to 2% in 2002. In Taiwan, Cheng and others (2004)
showed that the number of samples with nondetectable 3-MCPD
had increased from 29% to 46%. There was also a decrease in the
maximum detected 3-MCPD in samples. This demonstrates that
after publication of results, actions were taken by local authorities
to ensure that soy sauce and related products in the local market
are within the limits of maximum allowance. In certain countries,
manufacturers produced a combination of fermented and HVP
soy sauce (Luh 1995), and this type of combination can reduce the
contents of 3-MCPD while still increasing the sensory properties
of the products.
Genotoxicity of 3-MCPD
Genotoxicity refers to a chemical agent that damages genetic
information within a cell, causing mutations that may lead to
cancer. All mutagens are genotoxic, but not all genotoxic agents
are mutagens. 3-MCPD is categorized as a potentially carcinogenic
compound, and, thus, a review to evaluate the genotoxic potential
of 3-MCPD is important. Genotoxicity of 3-MCPD had been
reported in both in vitro and in vivo studies, and the findings show
that 3-MCPD is a genotoxic agent in vitro but is a nongenotoxic
agent in vivo (Schlatter and others 2002).
For in vitro genotoxicity, testing on reverse mutation has been
reported in Salmonella strains. Table 3 shows that positive geno-
toxicity was reported with both the presence and absence of Aro-
clor 1254-induced rat liver homogenate (S9) (Stolzenberg and
Hine 1980; Silhankova and others 1982; Zeiger and others 1988;
Ohkubo and others 1995). In the presence of the S9 factor,
3-MCPD has been shown to be genotoxic in bacteria. How-
ever, there have also been reports of negative genotoxicity in the
presence of S9 (Stolzenberg and Hine 1979; Silhankova and oth-
ers 1982; Majeska and Matheson 1983; Ohkubo and others 1995).
The difference between these 2 findings is the species and strains
of bacteria used. For positive results, in either the presence or
absence of S9, the bacteria and strain selected were Salmonella
TA100 (Stolzenberg and Hine 1980; Zeiger and others 1988;
Ohkubo and others 1995) and TA1535 (Silhankova and others
1982; Zeiger and others 1988). For negative results, in either the
presence or absence of S9, the bacteria selected were Salmonella
TA98 (Stolzenberg and Hine 1979; Silhankova and others 1982;
Zeiger and others 1988; Ohkubo and others 1995) and E. coli
(Silhankova and others 1982; Ohkubo and others 1995). It can
be concluded that 3-MCPD shows genotoxic potential only in
certain types and strains of bacteria. Different strains of Salmonella
resulted in different outcomes for the genotoxicity of 3-MCPD.
However, selected strains of E. coli showed consistent results for
positive genotoxicity with or without S9.
Yeast has also been used to evaluate the genotoxic potential of
3-MCPD. The results showed that 3-MCPD exerted potential
genotoxicity with the absence of S9 (Rossi and others 1983). This
is consistent with the findings from the reverse mutation in the
bacteria Salmonella TA98 (Zeiger and others 1988; Ohkubo and
others 1995). With the presence of S9, the genotoxic potential
of 3-MCPD is either reduced or removed from the test subject
system.
In mammalian cells in vitro, the evidence for the genotoxic po-
tential of 3-MCPD is inconsistent. Henderson and others (1987)
showed negative genotoxic results with the absence of S9 and pos-
itive results with the presence of S9. Their research was conducted
on the mouse lymphoma TK locus. Sister chromatid exchange
conducted on Chinese hamster V79 cells showed that 3-MCPD
was genotoxic either in the presence or absence of S9 (May 1991).
These findings are unpublished; thus, differences in the variables
of these investigations cannot be evaluated. Additionally, Painter
and Howard (1982), with related end point DNA synthesis inhi-
bition (HeLa cells), reported that 3-MCPD is not genotoxic in
the presence and absence of S9.
There is no consistency of data to prove the genotoxicity of
3-MCPD in vitro. In vivo data, however, consistently revealed that
3-MCPD is not genotoxic in the presence and absence of S9 (Jones
and others 1969; Epstein and others 1972; Jones and Jackson 1976;
Jaccaud and Aeschbacher 1989; Frei and Wurgler 1997; Fellows
2000; Marshall 2000). 3-MCPD exerts genotoxic potential in cer-
tain selected organisms and strains in vitro, but the results are not
as convincing in in vivo genotoxic studies; in vivo genotoxic studies
show that 3-MCPD is a nongenotoxic chemical.
Metabolism of 3-MCPD
The genotoxic potential of 3-MCPD has been found to be
inconclusive and species-related. This can be further explained
through the metabolism of 3-MCPD in physiological systems.
Two pathways of 3-MCPD metabolism were proposed by Jones
(1983): the microbial metabolic pathway and the mammalian
metabolic pathway. Both pathways involve the enzyme dehalo-
genase, where the chloride ion in 3-MCPD is removed. The end
product of the microbial pathway can be mercapturic acid or glyc-
erol; for the mammalian pathway, the end product is oxalic acid
(Figure 4).
There is no conclusive evidence to prove the metabolic path-
way of 3-MCPD in microbes. Van Den Wijngaard and others
(1989) proposed that microbes utilize the enzyme HHD to oxi-
dize 3-MCPD to glycidol but did not mention specifically which
microbes utilized the aforementioned pathway (they stated that the
microbes were Gram-positive). Glycidol is a genotoxic carcinogen
(Lee and others 2012) that has been classified as Group 2A (IARC
2014). Glycidol can be hydrolyzed to glycerol and, conversely,
glycidol can be deconjugated and acetylated to form mercapturic
acid (Lynch and others 1998).
Jones (1975) hypothesized that 3-MCPD has the samemetabolic
pathway in mammals and microbes ending with mercapturic
acid, though the nephrotoxic and reproductive toxicity exhibited
by 3-MCPD contradicts this idea. In the mammalian pathway,
3-MCPD is oxidized to 2-chloroacetaldehyde by alcohol
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dehydrogenase, which is converted to 3-chloro-2-
hydroxypropanoic acid (also known as chlorolactic acid).
Jones and others (1981) reported that chlorolactic acid has been
shown to inhibit respiration and lactate metabolism (playing an
important role in causing nephrotoxicity). Lee and others (2005b)
showed that chlorolactic acid could induce immunotoxic effects
in vitro. Chlorolactic acid suppressed T-lymphocytes, B lympho-
cytes, and the production of cytokines. This explains why rats fed
with high and medium concentrations of 3-MCPD showed signs
of morbidity and mortality (Lee and others 2005b). Jones and
others (1978) showed that glycidol is not the major metabolite of
3-MCPD in vivo. The end product in the mammalian pathway,
oxalic acid, has been found to cause kidney failure through the
formation of crystals of calcium oxalate. Calcium oxalate has been
associated with focal necrosis, mineralization, and impairment
of kidney function (EAEMP 2004). The pathway ending with
oxalic acid or propane-1,2-diol is the better explanation for the
metabolism of 3-MCPD in vivo, with intermediate products as
the causative agents of nephrotoxicity and reproductive toxicity.
Biomarkers of 3-MCPD
Biomarkers are characteristics that are objectively measured
and evaluated as an indicator of normal biological processes,
pathogenic processes, or pharmacologic responses to a therapeutic
intervention (Atkinson and others 2001). When the physiological
system is exposed to foreign substances, it will respond by releas-
ing biomarkers. Biomarkers are useful tools for disease detection,
prevention of further exposure to contaminants and evaluation of
the severity of exposure.
Jones (1975) investigated the metabolism of 3-MCPD in rats and
mice and isolated and identified 2 biomarkers from the animals’
urine: S-(2,3-dihydroxypropyl)cysteine (VII), and the correspond-
ing mercapturic acid N-acetyl-S-(2,3-dihydroxypropyl)cysteine
(VIII). Jones and Fakhouri (1979) reported the urinary metabo-
lites 1,3-DCP, N-acetyl-S-(2,3-dihydroxypropyl)cysteine, and
N,N-bis-acetyl-S,S’-(1,3-bis-cysteinyl)propan-2-ol in 3-MCPD-
exposed animals. Jones and others (1978) exposed labeled
3-MCPD to male rats to investigate the oxidative metabolism of
3-MCPD, and isolated β-chlorolactic acid (IV) and oxalic acid
(V) from the exposed rats’ urine. All the biomarkers found in the
urine of 3-MCPD-exposed rats were either from the bacterial
or putative mammalian pathways of 3-MCPD metabolism
(Figure 4). Since the exact metabolic pathway of 3-MCPD is yet
to be determined, there is no definitive way to prove that any of
the metabolites reported is directly related to 3-MCPD exposure.
In a study of the toxicological effects of chloropropanols on
rats, Li and others (2003) found that there was an increase in
N-acetyl-beta-D-glucosaminidase (NAG) activity for rats exposed
to 3-MCPD. They proposed that NAG in urine and in sperm
counts are sensitive biomarkers for 3-MCPD. Unfortunately, NAG
in urine is not a specific biomarker for 3-MCPD; NAG can also
be used to detect renal injury (Skalova 2005), which can be due
to various causes such as injury or dysfunction due to diabetes
mellitus, nephrotic syndrome, inflammation, vesicoureteral reflux,
urinary tract infection, hypercalciuria, urolithiasis, nephrocalci-
nosis, perinatal asphyxia, hypoxia, hypertension, heavy metal poi-
soning, and treatment with aminoglycosides, valproate, or other
nephrotoxic drugs. Li and others (2010) narrowed down the spe-
cific biomarker for 3-MCPD, using the metabonomic analysis for
specific biomarkers in male Wistar rats. The biomarker was deter-
mined and measured from the urine with ultra-performance liq-
uid chromatography/mass spectrometry (UPLC-MS). The study
found that high concentrations of galactosylglycerol were found in
urine of rats exposed to high concentrations of 3-MCPD, and this
biomarker can be detected as early as 10 d following exposure. To
increase the validity of the biomarkers found, this research could
be extended to other species of animals such as mini-pigs. The
relationship between the concentration of the biomarker, expo-
sure concentration, and exposure period would provide important
information. With a relationship established, exposure of humans
to 3-MCPD could be measured and would enable further valida-
tion of the adverse effects of 3-MCPD on the human biological
system.
Toxicity of 3-MCPD
Prior to 3-MCPD being reported to be potentially carcino-
genic, it was widely used as an antifertility treatment for rodents.
3-MCPD was the active ingredient in Epibloc, registered trade-
mark of Gametrices (Ericsson 1982), an effective rodenticide tar-
geting a specific rodent, Rattus norvegicus (Norway or common
brown rat). It renders the male rodent temporarily or perma-
nently infertile, depending on the concentration ingested. Jones
(1983) reported that the reproductive toxicology of 3-MCPD is
species-dependent. It will be effective for rats, rams, boars, guinea
pigs, hamsters, rhesus monkeys, and ejaculated human sperm but
ineffective in mice and rabbits. The mechanism of 3-MCPD an-
tifertility is the blockage of the glycolysis pathway (Stevenson and
Jones 1984). Glycolysis is an important pathway for sperm mo-
bility, as it compensates for the lack of oxidative phosphorylation
(Mukai and Okuno 2004; Miki 2007). The blockage of glycolysis
due to the action of (s)-3-MCPD in tyrosine protein phospho-
rylation will impair the 3’-5’-cyclic adenosine monophosphate
(cAMP)/protein kinase A (PKA) pathway in sperm (Zhang and
others 2012). It has been recently reported that 3-MCPD reduces
progesterone production in R2C rat Leydig cells (Sun and others
2013), and this report also stated that 3-MCPD will induce mor-
phological changes and DNA damage in Leydig cells, resulting in
apoptotic cell death.
Lee and others (2004) investigated the potential immunotoxi-
city of 3-MCPD in female Balb/c mice. In this study, 3-MCPD
was dissolved in water and administered by gavage for 14 d.
The exposure concentrations used were 0 (control), 25, 50, and
100 mg/kg. Food and water were given freely. Hematological
changes, histopathological changes, antigen-specific immunity (re-
sponse to sheep erythrocyte), proliferative potential of splenic
lymphocytes (T- and B-cell mitogens), and natural killer (NK)
cell activity (nonspecific immunity) were evaluated. After 2 wk,
no experiment-related mortality was observed. There were also
no significant changes in weight gained observed between the
control and exposed mice, though mice fed at the high dose were
found to have reduced thymus and spleen weights. There were sig-
nificant decreases of spleen and thymus cellularity for groups fed
with high concentrations of 3-MCPD. 3-MCPD also found to
significantly reduce the antibody-forming cell response in female
Balb/c mice exposed to a dose of 100 mg/kg dose. The research
concluded that 3-MCPD can disrupt the immune system of fe-
male mice exposed to a high-concentration dosage (100 mg/kg).
The major immune system modulated was antibody-forming
cell response, spleen and thymus cellularity, and NK cell activ-
ity. To further understand immunotoxicity response of 3-MCPD,
Lee and others (2005a) investigated the effect of 3-MCPD on the
thymic subset, delayed-type hypersensitivity, mixed-lymphocyte
reaction, and peritoneal macrophage activity. The experimental
settings were 3-MCPD dissolved with water and administered
57
through gavage to female Balb/c mice for 2 wk. The dosages were
0 (control), 25, 50, and 100 mg/kg. There were no significant
changes for the mixed-lymphocyte reaction and delayed-type hy-
persensitivity. There were significant decreases in CD4+CD8+
thymic subset and activity of peritoneal macrophage, but signifi-
cant increases in apoptosis of thymocytes in mice treated with high
dose of 3-MCPD. The findings of this research support the find-
ings of Lee and others (2004), 3-MCPD can reduce the immune
system of female Balb/c mice fed with 100 mg/kg 3-MCPD for
2 wk.
Carcinogenicity Study in Mice
A dermal study was conducted for 19 mo with 50 female
CHR/Ha Swiss mice. Fifty mice were subjected to solvent alone
as a control. 3-MCPD was dissolved in 0.1 mL acetone for ap-
plication in the study. A 2-mg dose was administered as a dermal
application 3 times a week for 19 mo. At the end of the treatment
period, no treatments related to neoplastic findings were reported
(Van Duuren and others 1974).
Similarly, a subcutaneous study was conducted for 19 mo with
50 female CHR/Ha Swiss mice (Van Duuren and others 1974).
Fifty mice were subjected to solvent alone as the control. 3-MCPD
was dissolved in tricaprylin for application, and 1 mg was injected
into each mouse once weekly. Local sarcoma was found at the site
of injection in 1 dosed and 1 control mouse. This study concluded
that 3-MCPD is not a carcinogenic compound.
In contrast, Cho and others (2008a) investigated the subchronic
toxicity of 3-MCPD in drinking water on B6C3F1 mice for
13 wk. Treatments of 0 (control), 5, 25, 100, 200, and 400 ppm
3-MCPDwere administered to 10 mice of each sex for all concen-
trations over a period of 13 wk. All mice survived the treatments,
but the body weight gained for male and female mice administered
with the 400 ppm dose was significantly lower compared to the
control. The relative kidney weights of males and females mice
treated with 200 and 400 ppm doses were significantly higher
than the controls without any corresponding histopathological
changes. A decrease in sperm motility was also reported for male
mice treated with 400 ppm. There was a significant increase in
the degeneration of the germinal epithelium for males given be-
tween 200 ppm and 400 ppm. A significant delay in the estrus
cycle was reported for female mice treated with 400 ppm, but no
histopathological changes in the reproductive organs were found.
The study concluded that the target organs for 3-MCPD toxicity
are the kidneys, testes, and ovaries.
Jeong and others (2010) conducted a carcinogenicity study on
3-MCPD administered in drinking water to B6C3F1 mice and
showed no carcinogenic potential. Their investigation lasted 104
wk, with 3-MCPD concentrations of 0, 30, 100, and 300/200
ppm. There were a total of 50 mice (males and females) for each
exposure concentration. The 300 ppm group was reduced to a
200 ppm dose during the research due to the toxic effects of
3-MCPD. In the report, the weight of the high-dosage mice
had significantly decreased and food and water consumption
were lower compared to the control mice. There was no
histopathological evidence to support differences in hematology
and serum biochemistry. No treatment-related neoplastic findings
were reported, and it was concluded that there was no evidence of
carcinogenic potential. The research was conducted in accordance
with OECD and ICH requirements for a satisfactory carcino-
genicity study (ICH 2008; OECD 2008). There are no conclusive
results regarding the carcinogenic potential of 3-MCPD in a
mouse test model (Table 4). Ta
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Carcinogenic Study in Rats
Weisburger and others (1981) reported a gavage study with
Sprague-Dawley (SD) rats for 72 wk and observation for 104 wk.
Twenty-six males and females were used for the study, but only
20 were used as controls. The dosage fed was 30/35 and 60/70
mg/kg-body weight. The dosage was increased after 10 wk. It
was reported that all of the rats fed with high concentrations of
3-MCPD had lower weights compared with the controls. There
was no treatment-related neoplasticity found in any of the research
subjects.
Sunahara and others (1993), as reported by the WHO (Schlatter
and others 2002), studied the carcinogenicity of 3-MCPD in
drinking water with Fisher 344 rats. In the study, 4 groups
of 50 pathogen-free Fisher rats of each sex (male and female)
were given 0 (control), 20, 100, and 500 mg/L 3-MCPD (98%
purity) doses of 3-MCPD for 104 wk. There was a significant
decrease in food intake and water consumption in both males and
females treated with 500 mg/L 3-MCPD, which contributed to a
significant body weight reduction for the high-dosage treatment.
The mortality rate was unaffected by treatment, with more than
42% of rats terminated at the conclusion of the experiment. No
treatment-related clinical signs were noted by the hematological
and blood clinical parameters. Chronic progressive nephropathy
(CPN) was found in all 3-MCPD-exposed rats where female rats
were found to be more severely affected than male rats. Dose-
related incidence of hyperplasia and/or tumors was observed
in all 3-MCPD-treated groups, with increases in kidney, testis,
mammary gland, and pituitary gland. The research concluded that
3-MCPD increases the incidence of renal and testicular
Leydig-cell tumors in a dose-dependent pattern.
Another toxicity study was conducted by Cho and others
(2008b) on 50 male and female SD rats. The dosages involved
in this research were 0, 25, 100, and 400 ppm administered for
2 y. The water intake for rats treated with 400 ppm was sig-
nificantly lower than for the controls, contributing to a signifi-
cantly lower weight for the high dosage groups (both genders).
At the end of the research, there was no significant difference in
the survival rate between males and females. The rate of survival
for both genders was less than 50% due to spontaneous pitu-
itary tumors in both sexes. CPN were observed in all 3-MCPD
exposed groups, consistent with the findings of Sunahara and
others (1993), though different in species of rats in the experi-
ment settings. The authors concluded that 3-MCPD is a carcino-
gen as there were incidences of kidney renal tubule carcinomas
in both male and female rats and Leydig cell tumors in male SD
rats.
Barocelli and others (2011) conducted a 90-d toxicity study of
3-MCPD and 3-MCPD palmitic ester, but only the toxicity of
3-MCPD is discussed here. The toxicology study used Wistar rats
treated with 3 concentrations of 3-MCPD: high (14.75 mg/kg),
medium-high (3.68 mg/kg), and low (0.92 mg/kg). For each
concentration, there were 10 rats as a control and 20 rats for the
treatment. The 3-MCPD dosage in the research was diluted with
corn oil. Dosages of different concentrations of 3-MCPD were
administered via oral gavage, and food and water consumption
was freely. At the conclusion of the research, all male rats survived,
but there were 7 deaths in the high concentration-treated female
rats and 1 death in the medium-high female group. The Wistar
rat model shows that short-term, high dosages of 3-MCPD are
fatal to female rats. All surviving test subjects, male and female,
also showed signs of morbidity. In contrast with the findings of
Sunahara and others (1993) and Cho and others (2008b), the
rats in this study had a weight increase. The research shows that
3-MCPD will cause renal and testis damage.
According to results from short-term testing with rats, 3-MCPD
has been shown to be nephrotoxic and reproductively toxic. Ad-
ditionally, long-term toxicity tests with rats showed that 3-MCPD
can induce adenoma and/or carcinoma. Although the test results
are animal-specific, it certainly cannot be ignored that 3-MCPD
could potentially be carcinogenic to the human physiological sys-
tem. Toxicity research on animals such as mini-pigs will give a bet-
ter understanding of the mechanisms and the effect of 3-MCPD
on the human physiological system, as mini-pigs share basic physi-
ology with humans (OECD 2012). Postmortem information from
these studies will further confirm the target organs, genotoxicity,
and carcinogenic mechanisms of 3-MCPD.
Methods of Detection—Advantages and
Disadvantages
At present, several techniques have been developed and
reported for the quantification of 3-MCPD. Most of these
techniques require a process to change 3-MCPD into its
derivatives and analyze with gas chromatography (GC) or gas
chromatography-mass spectrometry (GC-MS). Chloropropanols,
including 3-MCPD, were first detected by Velisek and others
(1978) in protein hydrolysate by isolation of neutral fractions
using GC. There was no LOD reported in the literature. After
this research was published, several quantification methods fol-
lowed and most of them involve using a derivatization agent such
as phenylboronic acid (PBA), bis(trimethylsiyl)trifluoroacetamide
(BSTFA), heptafluorobutyrylimidazole (HFBI), heptafluo-
robutyric anhydride (HFBA), ketal/acetonide formation, and
periodate oxidation (Table 5). There are also methods that do not
utilize the derivatization process, but a majority of these have a
higher LOD than the requirement set by the EU (Table 1).
Owing to the complexity of food matrices and the low
concentration of 3-MCPD, prior to derivatization, a procedure
to extract or clean up the 3-MCPD is required in order to obtain
a cleaner chromatogram and a higher recovery, and to lower
the required quantity of derivatization agent. To derivatize in an
anhydrous environment, solid-phase extraction will be required
to extract 3-MCPD from the aqueous sample into the anhydrous
solvent. 3-MCPD in food samples will first be extracted into
saline water. The 3-MCPD-extracted saline water will then be
loaded onto a chromatography column, with diatomaceous earth
as the stationary phase and a protic solvent as the mobile phase.
The purpose of using a protic solvent to extract 3-MCPD from
saline water is due to the polarity of 3-MCPD. A solid-phase
extraction technique is based on liquid–liquid extraction, but
possesses major advantages over conventional liquid–liquid extrac-
tion, such as the absence of emulsion formation, the gain of higher
yields and cleaner extracts, and savings on the uses of solvent and
time. The collected eluate is dried to dryness or near dryness and
subjected to derivatization. The derivatized 3-MCPD is then dis-
solved in an organic solvent and injected into a GC column. There
are also prepacked disposable supported liquid extraction columns
available on the market, such as Chem Elut (Agilent Technologies
2014) and EXtrelut (Merck Milipore 2014), which can be used
to extract 3-MCPD. Only PBA derivatization and periodate
oxidation can be done in an aqueous environment. Divinova´ and
others (2004) and Breitling-Utzman and others (2005) reported
the derivatization of 3-MCPD with PBA in an aqueous environ-
ment. Divinova´ and others (2004) first extracted 3-MCPD from
food samples with a hexane: acetone mixture. The 3-MCPD in
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hexane: acetone was then extracted into water with liquid–liquid
extraction. The aqueous 3-MCPD was dried to dryness and
derivatized with acetone/water-diluted PBA. Breitling-Utzman
and others (2005) simplified the extraction method by directly
extracting 3-MCPD from food samples into saline water and
derivatizing it with acetone: water-diluted PBA. After the deriva-
tization, the dioxaborolane products were dissolved in hexane and
injected into a GC column. As compared with the extraction for
anhydrous derivatization, the PBA extraction method is much
simpler and faster, and does not use harmful organic solvents.
For detection of 3-MCPD without derivatization, Spyres
(1993) directly quantified 3-MCPD with gas chromatography
coupled with electrolytic conductivity detection (GC-ECD), but
only achieved a 1 mg/kg detection limit. Xing and Cao (2007)
reported that instead of using GC, capillary electrophoresis with
electrochemical detection (CE-ECD) was used and an LOD of
0.13 mg/kg was achieved. Although a different instrument was
utilized, the LOD without derivatization was still high. Leung
and others (2003) developed a molecular imprinted polymer
(MIP) that is able to function as a potentiometric chemosensor
for 3-MCPD in aqueous samples. Unfortunately, the limited
range of quantification has restricted the use of this method, and
it will require further improvements. However, the 3-MCPD
MIP developed can be used to extract 3-MCPD from samples,
followed by derivatization and quantification by GC-MS.
PBA can be used to derivatize 3-MCPD, as it reacts specifi-
cally with 1,2-diol and 1,3-diol. PBA has been widely used as a
derivatizing agent for glucose detection and for the development
of a biomimetic sensor to determine blood glucose levels. This
derivatizing agent reacts with the 1,2-diol of 3-MCPD and forms
a dioxaborolane derivative, which dissolves in a nonpolar solvent.
The detection of 3-MCPD with PBA derivatization was first re-
ported by Rodman and Ross (1986). The PBA derivatization of
3-MCPD was reported to be done in an anhydrous environment
and detected with gas chromatography-matrix isolation-Fourier
transform infrared spectrometry (GC-MI-FIR). Pesselman and
Feit (1988) successfully derivatized 3-MCPD with PBA in an
aqueous environment and extracted the derivatives with hexane
prior to identification with GC-ECD. This had proven that deriva-
tization of 3-MCPD with PBA can be done in aqueous condition.
Plantinga and others (1991) and Anon (1995) applied PBA as a
derivatization agent but quantifiedwith gas chromatography-flame
ionization detection (GC-FID). The detection limit established
was between 0.5 and 1 mg/kg. The method was not sensitive
enough to detect 3-MCPD as required by the EU. To increase the
sensitivity of the method of derivatization by PBA, IARC (1994)
detected the derivative of 3-MCPD with gas chromatography-
mass spectrometry-selective ion monitoring (GC-MS-SIM). The
detection limit improved to between 0.03× 10−1 and 0.01 mg/kg.
Both Divinova´ and others (2004) and Huang and others (2005) us-
ing GC-MS-SIM had detection limits of 0.03 × 10−1 and 3.87 ×
10−3 mg/kg, respectively. Kuballa and Ruge (2003) quantified
3-MCPD with gas chromatography-tandem triple quadrupole
mass spectrometry (GC-MS/MS MRM). The detection limit was
in accordance with that required by the EU. Derivatization with
PBA has been proven to be effective with the conditions that it
must be quantified using GC coupled with a sensitive detector.
PBA-derivatized 3-MCPDs produce intense characteristic ions,
which is good for low-concentration detection but lack of con-
firmation of the ions (Table 6). The other drawback of PBA as
a derivatizing agent is that it is required in high concentration.
The excess PBA is detrimental to the chromatography system
Table 6–Characteristic ions of PBA derivatized 3-MCPD and 3-MCPDd5
(Hamlet and Sadd 2009).
Analytes MW [M]+− [M-CH2Cl]+ Other structurally
significant ions
3-MCPD 196 196/198a 146/147b 103/104b
[Ph-BO]+− 91
[C7H7]+
3-MCPDd5 201 201/201a 149/150b 103/104b
[Ph-BO]+− 93
[C7H5D2]+
aIsotopic chlorine cluster ion.
bIsotopic boron cluster ion.
and has to be removed prior to injection (Weisshaar and Perz
2010). Breitling-Utzman and others (2005) removed the excess
PBA through precipitation by storing the vials at –18 °C for 12
h prior to GC injection. The removal of PBA cannot be done
through neutralization with an alkaline agent because PBA is a
diol, not an acid.
Meierhans and others (1998) developed a sensitive method for
the determination of 3-MCPD with a capillary GC-MS using
derivatization by acetone in toluene-4-sulfonic acid monohydrate.
The LOD was 0.01 × 10−1 mg/kg. Diols functional group in the
3-MCPD will react with acetone and result in the formation of
cyclic acetals and ketals. The reaction had to be performed in an
anhydrous environment, as the formed acetals are moisture sen-
sitive and will undergo hydrolysis into aldehyde or ketone and
alcohol (Carey 2000). Owing to the sensitivity of the deriva-
tization method to moisture, 3-MCPD extraction for acetone
derivatization has to be done in anhydrous organic conditions,
preferably by solid-phase extraction, unlike the PBA extraction
method where 3-MCPD can be extracted into water prior to
derivatization. Dayrit and Nin˜onuevo (2004) utilized acetone in
toluene-4-sulfonic acid monohydrate to quantify 3-MCPD, with
3-MCPDd5 as the internal standard. The LOD achieved was 1.20
× 103 mg/kg. Re´tho and Blanchard (2005) modified the proce-
dure of Meierhans and others (1998) by filtering the derivative
3-MCPD with a basic aluminum oxide cartridge, achieving an
LOD of 0.01 × 10−1 mg/kg. The disadvantage of this method is
that acetone used in the derivatization contains moisture and an
additional step will be required to remove it. It is very important to
ensure that all glassware used in this method is dry, as the end prod-
ucts will react with water. The advantage of acetone-derivatized
3-MCPDs is the intense ions of the analytes that are helpful for
low-concentration detection, but the limited characteristics of the
ions are a drawback to their confirmation (Table 7). The catalyst
toluene-4-sulfonic acid monohydrate also has to be removed from
the end products. Becalski and others (2013) improved the method
by replacing the aliphatic ketones with cyclic ketones (cyclohex-
anone), which provided more resistant characteristic ions. They
also replaced the toluene-4-sulfonic acid monohydrate with a solid
catalyst (Nafion and Amberlyst), which could be easily removed
at the end of derivatization. The 1,3-dioxolane of 3-MCPD was
quantified by GC-MS, where the LOD achieved was between
0.01 × 10−1 and 0.03 × 10−1 mg/kg.
A small number of studies have utilized BSTFA as the derivati-
zation agent. 3-MCPD has to be extracted using a solid-phase ex-
traction method, prior to the silylation derivatization by BSTFA.
This idea was first published by Kissa (1992), where 3-MCPD
was derivatized by BSTFA and quantified with GC-FID. The
LOD for the method used was 5.00 mg/kg, which was too
high compared with the requirements of the EU. Bode´n and
61
Table 7–Characteristic ions of dioxolane/dioxane derivatized 3-MCPD and 3-MCPDd5 (Hamlet and Sadd 2009).
Derivatizing agent Analytes MW [M-CnH2n+1]+ Other structurally significant ions
Acetone 3-MCPD 150 135/137a 43[C2H3O]+
3-MCPDd5 155 140/142a 43[C2H3O]+
3-Pentanone 3-MCPD 178 149/151a 57[C3H5O]+
3-MCPDd5 183 154/156a 57[C3H5O]+
4-Heptanone 3-MCPD 206 163/165a 71[C4H7O]+
3-MCPDd5 211 168/170a 71[C4H7O]+
Cyclohexanone 3-MCPD 262 191/193a 99[C6H11O]+
3-MCPDd5 267 196/198a 99[C6H11O]+
aIsotopic chlorine cluster ion.
Table 8–Characteristic ions of HFB derivatized 3-MCPD and 3-MCPDd5 (Hamlet and Sadd 2009).
Analytes MW [M-CH2Cl]+ [M-C3F7CO2]+ [M-C3F7CO2CH2]+ [M-C3F7CO2-HCl]+ [M-C3F7CO2-C3F7CO2H]+
3-MCPD 502 453 289/291a 275/277a 253 75/77a
3-MCPDd5 507 456 294/291a 278/280a 257 79/81a
aIsotopic chlorine cluster ion.
others (1997) derivatized with BSTFA coupled with GCMS-SIM.
The detection limit was 0.04 mg/kg. Gonzalez and others (2011)
combined solid-phase extraction with GC-MS to compare the ef-
ficiency of the derivatizing activities of BSTFA and HFBI. It was
found that the LOD for BSTFA is 1.12 × 10−2 mg/kg, which
is low enough to quantify 3-MCPD according to the EU. The
research also found that BSTA was a better derivatization agent
compared to HFBI, as derivatization by BSTFA demonstrated
greater stability over time compared to HFBI. Racamonde and
others (2011) determined the levels of chloropropanols in food
using BSTFA as the derivatization agent and achieved a limit of
quantification (LOQ) of 0.16 × 10−2 mg/kg. Lee and others
(2007) determined the concentration of 3-MCPD using solid-
phase micro-extraction (SPME) derivatized with N-methyl-N-
(trimethylsilyl)-trifluoroacetamide (MSTFA) and quantified with
GC-MS. 3-MCPD was extracted with an 85-μm polyacrylate-
coated fiber and head-spaced derivatized. The LOD achieved was
3.91 × 103 mg/kg. BSTFA and MSTFA are better alternatives
than HFBI and HFBA, as the end product is stable. The disadvan-
tage of BSTFA and MSTFA as derivatizing agents is that silicone
residues might accumulate in the detector. However, BSTFA and
MSTFA will not harm the GC column as they are evaporated
prior to GC injection. The derivatives of BSTFA and MSTFA
have ions of low mass, thus resulting in a reduced sensitivity of the
method.
The method based on the heptafluorobutyrate derivative is the
only method that allows the control of a wide range of samples
(Re´tho and Blanchard 2005). 3-MCPD will have to be extracted
with solid-phase extraction on diatomaceous earth before the
acylation derivatization process. Brereton and others (2001) ex-
tensively studied this method with the utilization of 3-MCPDd5
as an internal standard. Most if not all method of quantification
for 3-MCPD utilized the deuterated 3-MCPD internal standard.
The method became the European Standard (European Standard
2005) and was adopted by the AOAC (AOAC 2002). The first
research performed using HFBI was by van Bergen (1992), where
GC-ECD and GC-MS were used to quantify chloropropanols,
including 3-MCPD. The LOD is between 0.01 and 0.10 mg/kg.
Hamlet and Sutton (1997) combined HFBI derivatization with
GC-MS/MS MRM and achieved a detection limit of 0.05 ×
10−1 mg/kg, which was low enough to meet the EU requirement.
Robert and others (2004) and Bel-Rhlid and others (2004) re-
searched the combination of HFBI and GC-MS, and the LODwas
0.05 × 10−1 mg/kg. The advantage of HFBI is that it is not acidic,
and thus will not harm the column. Besides this, the excess HFBI
in the derivatization system will also protect the column, as it will
react with co-extracted compounds that could harm the column.
HFBI-derivatized 3-MCPD produces a number of characteristic
ions that are useful for confirmation of the analytes, making it
more favorable for the derivatization of 3-MCPD (Table 8). The
challenge of HFBI is that the derivatization has to be performed
in an anhydrous environment. HFBI is also an expensive deriva-
tizing agent. HFBA is a cheaper derivatization reagent that can
replace HFBI and still provide HFB-derivatized characteristic
ions.
Derivatization with HFBA to quantify 3-MCPDwas conducted
by Chung and others (2002) using a combination HFBAwith GC-
MS, and the LOD obtained was 0.05 × 10−1 mg/kg. Matthew
and Anastasio (2000), with the same derivatization agent and GC-
ECD, achieved a lower and more sensitive LOD between 0.07 ×
10−2 and 0.17 × 10−2 mg/kg. Abu-El-Haj and others (2007),
using HFBA coupled with GC-MS-SIM, developed a method
with an LOD of 0.01 × 10−1 mg/kg. HFBA can provide almost
the same sensitivity as HFBI with a suitable catalyst. Unfortu-
nately, HFBA derivatization also must be performed in an anhy-
drous environment. The acidic characteristic of HFBA was one
of the concerns, as it may reduce the lifespan of the GC column.
However, this can be solved by the washing step with water before
injection.
There is also a novel approach using periodate oxidation to
derivatize 3-MCPD and quantification with HPLC-FLD as re-
ported by Hu and others (2013). The fluorescence derivatization
procedure was modified from Huang and Waxman (1999) for the
determination of chloroacetaldehyde. The method was reported
to be able to quantify 3-MCPD up to 0.36 × 10−3 mg/kg. How-
ever, this method was found not to be suitable for quantification
of 3-MCPD in soy and soy-related sauces, as the dark color of the
sample matrix will render the reading of fluorescence ineffective.
Conclusions
Research on 3-MCPD has been intensive in the past 10 y, and
many countries already have regulations on the levels of 3-MCPD
allowed in food, yet foods with a high concentration of 3-MCPD
are still widely available to consumers. Better enforcement of reg-
ulations and more efficient removal methods must be introduced
to ensure that the concentrations of 3-MCPD in foods are within
the required levels. Improvement in the analytical field would be
an advantage to food safety; food quality would be compromised
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if the quantification of 3-MCPD is too time-consuming. Most
analytical methods used for quantifying 3-MCPD require sample
clean-up coupled with a sensitive instrument such as a GC-MS.
Therefore, a method based on a chemosensor or biosensor would
be an advantage, as sensors are robust and specific. The develop-
ment of user intervention-free sensors for the rapid determination
of 3-MCPD will provide an alternative to the existing standard
methods, allowing faster quantification of 3-MCPD, which, in
turn, would allow immediate actions to be taken to ensure the
safety of food in the marketplace.
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